Compass Therapeutics, Inc.
CMPX • NASDAQ
Compass Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Thomas J. Schuetz, with a market cap of $938.3M.
CEOThomas J. Schuetz
Next Earnings
Upcoming earnings announcement for Compass Therapeutics, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.10
Revenue Estimate
-$600.0K
Earnings History
Past 12 earnings reports for Compass Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Q4 2025 | -$0.09Est: -$0.09 | 0.0% | - | — |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.08Est: -$0.14 | +42.9% | - | — | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$0.14Est: -$0.12 | -16.7% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.12Est: -$0.11 | -9.1% | - | — | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$0.11Est: -$0.09 | -22.2% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.08Est: -$0.11 | +27.3% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.10Est: -$0.10 | 0.0% | $850.0K | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.08Est: -$0.11 | +27.3% | - | — | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.11Est: -$0.09 | -22.2% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.08Est: -$0.11 | +27.3% | - | — | — |
| Aug 3, 2023 | Q2 2023 | -$0.09Est: -$0.08 | -12.5% | - | — | 10-Q |
| May 4, 2023 | Q1 2023 | -$0.06Est: -$0.11 | +45.5% | - | — | — |